The Latest Headlines at Riverton Roll
Stephens Reaffirms “Overweight” Rating for CoStar Group (NASDAQ:CSGP)
Stephens restated their overweight rating on shares of CoStar Group (NASDAQ:CSGP – Free Report) in a research note released on Wednesday, Benzinga reports. The firm currently has a $105.00 price target on the technology company’s... More of this article »
Cyclacel Pharmaceuticals (NASDAQ:CYCC) Earns Hold Rating from Analysts at StockNews.com
StockNews.com started coverage on shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC – Free Report) in a research report released on Wednesday. The brokerage issued a hold rating on the biotechnology company’s stock. Cyclacel... More of this article »
CoStar Group (NASDAQ:CSGP) Earns “Outperform” Rating from William Blair
William Blair reaffirmed their outperform rating on shares of CoStar Group (NASDAQ:CSGP – Free Report) in a report issued on Wednesday morning, RTT News reports. William Blair also issued estimates for CoStar Group’s Q3... More of this article »
Craig Hallum Begins Coverage on DiaMedica Therapeutics (NASDAQ:DMAC)
Craig Hallum assumed coverage on shares of DiaMedica Therapeutics (NASDAQ:DMAC – Free Report) in a research report report published on Wednesday morning, Marketbeat.com reports. The brokerage issued a buy rating and a $8.00 price... More of this article »
DexCom (NASDAQ:DXCM) Cut to “Hold” at StockNews.com
StockNews.com cut shares of DexCom (NASDAQ:DXCM – Free Report) from a buy rating to a hold rating in a research note published on Tuesday. Other equities research analysts have also issued research reports about the stock. Raymond... More of this article »
Consolidated Water (NASDAQ:CWCO) Cut to “Hold” at StockNews.com
StockNews.com lowered shares of Consolidated Water (NASDAQ:CWCO – Free Report) from a buy rating to a hold rating in a research report released on Wednesday morning. Consolidated Water Stock Up 1.6 % Shares of NASDAQ CWCO opened... More of this article »
Medpace (NASDAQ:MEDP) Upgraded to Buy at StockNews.com
StockNews.com upgraded shares of Medpace (NASDAQ:MEDP – Free Report) from a hold rating to a buy rating in a research note issued to investors on Tuesday. Several other equities analysts also recently commented on the stock.... More of this article »
Remark (NASDAQ:MARK) Earns Sell Rating from Analysts at StockNews.com
StockNews.com assumed coverage on shares of Remark (NASDAQ:MARK – Free Report) in a research report sent to investors on Wednesday. The brokerage issued a sell rating on the information services provider’s stock. Remark... More of this article »
Lakeland Industries (NASDAQ:LAKE) Earns Buy Rating from Analysts at Maxim Group
Maxim Group started coverage on shares of Lakeland Industries (NASDAQ:LAKE – Free Report) in a research note released on Wednesday morning, Marketbeat Ratings reports. The firm issued a buy rating and a $22.00 price objective... More of this article »
HealthStream (NASDAQ:HSTM) Cut to “Buy” at StockNews.com
StockNews.com cut shares of HealthStream (NASDAQ:HSTM – Free Report) from a strong-buy rating to a buy rating in a research report sent to investors on Wednesday. Several other research firms have also recently commented on HSTM.... More of this article »
Oppenheimer Trims Incyte (NASDAQ:INCY) Target Price to $84.00
Incyte (NASDAQ:INCY – Free Report) had its price target cut by Oppenheimer from $92.00 to $84.00 in a research report report published on Wednesday morning, Benzinga reports. They currently have an outperform rating on the biopharmaceutical... More of this article »
Morgan Stanley Direct Lending (MSDL) vs. Its Rivals Critical Survey
Morgan Stanley Direct Lending (NYSE:MSDL – Get Free Report) is one of 670 public companies in the “Holding & other investment offices” industry, but how does it weigh in compared to its rivals? We will compare... More of this article »
Ameriprise Financial (NYSE:AMP) PT Raised to $480.00
Ameriprise Financial (NYSE:AMP – Free Report) had its price target upped by Royal Bank of Canada from $470.00 to $480.00 in a report published on Wednesday, Benzinga reports. The firm currently has an outperform rating on the... More of this article »